Skip to content

Eventos

 

Noche de Casino Negro y Azul

 

La Noche de Casino Negro y Azul es una velada divertida para la comunidad de trastornos hemorrágicos y sus patrocinadores. Los asistentes disfrutan de una noche de buena comida, baile, juegos de casino y premios, mientras recaudan dinero para los programas y servicios de la Fundación de Trastornos Hemorrágicos Lone Star.


La Noche de Casino Negro y Azul de Estrellas, se programó para el 22 de marzo de 2020. Estamos buscando opciones para reprogramar el evento. ¡Visítenos nuevamente para mantenerse actualizado y para más detalles!

Photo Apr 13, 6 55 02 PM
Photo Apr 13, 6 55 02 PM
Photo Apr 13, 6 55 13 PM
Photo Apr 13, 6 55 13 PM
Photo Apr 13, 9 32 22 PM
Photo Apr 13, 9 32 22 PM
Photo Apr 13, 9 49 31 PM
Photo Apr 13, 9 49 31 PM
Photo Apr 13, 9 51 18 PM
Photo Apr 13, 9 51 18 PM
Photo Feb 24, 8 18 07 PM
Photo Feb 24, 8 18 07 PM
Photo Feb 24, 8 20 05 PM
Photo Feb 24, 8 20 05 PM
Photo Feb 24, 8 25 44 PM
Photo Feb 24, 8 25 44 PM
Photo Feb 24, 8 29 09 PM
Photo Feb 24, 8 29 09 PM
Photo Feb 24, 8 30 35 PM
Photo Feb 24, 8 30 35 PM
Photo Feb 24, 9 36 29 PM
Photo Feb 24, 9 36 29 PM
previous arrow
next arrow

News from HFA

  • May is Hepatitis Awareness Month

    In 2001, the Centers for Disease Control and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral hepatitis. In the 1980s and ’90s, thousands of people with hemophilia contracted HIV and hepatitis C (HCV) from the contaminated blood supply transmitted by clotting factor products. The post May is Hepatitis Awareness Month appeared first on Hemophilia Federation of America.

  • FDA Approves One-Time Gene Therapy for Adults with Hemophilia B

    From Pfizer: Pfizer Inc. announced that the US Food and Drug Administration has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing The post FDA Approves One-Time Gene Therapy for Adults with Hemophilia B appeared first on Hemophilia Federation of America.

  • Advocacy News: March 2024

    Word From Washington Federal Agencies According to the latest KFF Medicaid Unwinding Enrollment Tracker, more than 19 million Americans have lost Medicaid coverage since states were allowed to resume eligibility verifications following the COVID-19 public health emergency (PHE). At least 70 percent of Medicaid terminations continue to be for procedural reasons (such as not returning The post Advocacy News: March 2024 appeared first on Hemophilia Federation of America.

  • Update on Smithsonian Institution Project to Archive Bleeding Disorders History

    Hemophilia Federation of America announced, in April of 2019, a partnership with the Smithsonian Institution to document the history of the bleeding disorders community, with a focus on the tragic experiences with contaminated blood, and we’re pleased to announce the first phase of the project is complete.   HFA began an initiative to collect artifacts and The post Update on Smithsonian Institution Project to Archive Bleeding Disorders History appeared first on Hemophilia Federation of America.

  • Advocacy News: February 2024

    Word From Washington State of the States The post Advocacy News: February 2024 appeared first on Hemophilia Federation of America.